Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy source : Www.fda.gov save search
FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes
Published: 2023-10-24 (Crawled : 20:00) - fda.gov
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: -0.89%
H: 0.09%
C: -1.04%
fda rare blood therapy
FDA Approves First Gene Therapy for Adults with Severe Hemophilia A
Published: 2023-06-29 (Crawled : 22:00) - fda.gov
BMRN | News S | $90.48 -0.43% -0.43% 1.3M
|
Health Technology
|
| O: 1.2%
H: 1.97%
C: -3.69%
fda therapy
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy
Published: 2023-06-22 (Crawled : 18:00) - fda.gov
SRPT | $117.885 0.51% 0.48% 550K
|
Health Technology
|
| O: -3.2%
H: 0.03%
C: -4.89%
fda treatment duchenne therapy
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 0.44%
H: 2.01%
C: 0.82%
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: 2.03%
H: 3.33%
C: 0.07%
RGNX | News | $17.01 -2.8% -2.88% 410K
|
Health Technology
|
| O: 0.91%
H: 2.93%
C: 2.79%
BIIB | $192.13 -1.55% -1.57% 1.3M
|
Health Technology
|
| O: 0.19%
H: 2.32%
C: 1.7%
disease fda gene therapies therapy gene therapy rare
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals
Published: 2021-09-02 (Crawled : 15:15) - fda.gov
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
fda therapy drug approval fda ide milestone
FDA approves add-on therapy for patients with genetic form of severely high cholesterol
Published: 2021-04-01 (Crawled : 18:56) - fda.gov
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
| Email alert
Add to watchlist
therapy fda fda approval approval cholesterol
Competitive Generic Therapy Approvals
Published: 2021-03-31 (Crawled : 16:34) - fda.gov
ANIP S | $65.5 -0.09% -0.09% 120K
|
Health Technology
|
| O: 0.61%
H: 9.81%
C: 9.05%
therapy approval
Competitive Generic Therapy Approvals
Published: 2021-03-15 (Crawled : 00:00) - fda.gov
ANIP S | $65.5 -0.09% -0.09% 120K
|
Health Technology
|
| O: 0.12%
H: 2.78%
C: 1.95%
therapy approval
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.